<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>22</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Meta-analysis of the association between miR-499 gene polymorphism and hepatocellular carcinoma HCC genetic susceptibility</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-justify:newspaper&quot;&gt;&lt;span style=&quot;text-kashida-space:50%&quot;&gt;&lt;span style=&quot;line-height:119%&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Background&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;The link between the miR-499(rs3746444) gene polymorphism and genetic predisposition to hepatocellular carcinoma (HCC) was thoroughly assessed in this study. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;This study used Rev-Man 5.41 statistical software to conduct a meta-analysis of case-control studies that investigated the relationship between genetic susceptibility to HCC and the miR-499 gene or the rs3746444 locus polymorphism. The articles were searched in PMC, PubMed, and other databases. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;In this analysis, 15 publications were used, with 4901 normal individuals serving as the control group and 3366 HCC patients as members of the experimental group. The findings showed that the risk of getting HCC was higher in those with the AA (95%CI (0.64, 0.94), I2 = 71%, P = 0.009) or AG (95%CI (1.01, 1.40), I2 = 58%, P = 0.04) genotypes. The risk of HCC was minimal when the genotype was GG (95%CI (0.79, 1.50), I2=56%, P = 0.60). A statistical difference was found between the G allele (95%CI (1.13, 1.69), I2 = 60%, P=0.002), while no significant difference was found between the two groups with respect to the A allele (95%CI (0.56, 1.15), I2 = 79%, P = 0.23). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Conclusions: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;There was a strong link between the polymorphism of miR-499 gene and the genetic predisposition to hepatocellular cancer. Therefore, the polymorphism of the miR-499 gene can be utilized as a predictor of liver cancer occurrence, which is highly relevant for the early detection and management of liver cancer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Hepatocellular carcinoma, genetic susceptibility, miR-499 polymorphism, meta-analysis, liver cancer.</keyword>
	<start_page>733</start_page>
	<end_page>738</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-1233&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>C. </first_name>
	<middle_name></middle_name>
	<last_name>Xiaobo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460028073</code>
	<orcid>7900319475328460028073</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Infection, Xiaogan Central Hospital, Xiaogan 432000, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>D. </first_name>
	<middle_name></middle_name>
	<last_name>Hui</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460028074</code>
	<orcid>7900319475328460028074</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Oncology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming 650051, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y. </first_name>
	<middle_name></middle_name>
	<last_name>Juan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yj87920@126.com </email>
	<code>7900319475328460028075</code>
	<orcid>7900319475328460028075</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Xiaogan Central Hospital, Xiaogan 432000, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
